VANGUARD GROUP INC 13D and 13G filings for CG Oncology, Inc. Common stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 5:13 pm Sale | 2026-03-13 | 13G | CG ONCOLOGY INC CGON | VANGUARD GROUP INC | 0 0.000% | -6,577,281 (Position Closed) | Filing |
| 2025-10-30 2:54 pm Purchase | 2025-09-30 | 13G | CG ONCOLOGY INC CGON | VANGUARD GROUP INC | 6,577,281 8.620% | 1,495,929 (+29.44%) | Filing |
| 2024-11-12 2:30 pm Unchanged | 2024-09-30 | 13G | CG ONCOLOGY INC CGON | VANGUARD GROUP INC | 5,081,352 7.570% | 0 (Unchanged) | Filing |
| 2024-11-04 10:22 am Purchase | 2024-09-30 | 13G | CG ONCOLOGY INC CGON | VANGUARD GROUP INC | 5,081,352 7.570% | 5,081,352 (New Position) | Filing |